The stock zoomed 18.27 percent to Rs 22.65 at the BSE. On the NSE, it climbed 18.75 percent to Rs 22.80. Dilip Shanghvi is the Sun Pharmaceuticals promoter. The company has signed definitive agreements with Dilip Shanghvi Family and Associates (DSA) for equity investments of Rs 1,800 crore in Suzlon Energy.

Post allotment, DSA shareholding will rise to 23 percent (based on current shareholding), while the Tanti Family will hold 24 percent shares.
Shanghvi and family also announced an open offer to acquire 26 percent stake in Suzlon at Rs 18 per share aggregating to Rs 2,837 crore.
Management control will remain with Tanti family by virtue of pooling arrangement for voting.

Latest News  from Business News Desk